Bellevue Asset Management »

Cardiovascular Systems shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Cardiovascular Systems shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Cardiovascular Systems

Tip: Access up to 7 years of quarterly data

All positions including Cardiovascular Systems held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiovascular Systems by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2015-12-31 $454k 30k 15.13
2015-09-30 $475k 30k 15.83
2015-06-30 $529k 20k 26.45

More positions owned by Bellevue Asset Management

Celgene Corporation
Biogen Idec (BIIB)
Gilead Sciences (GILD)
Amgen (AMGN)
Regeneron Pharmaceuticals (REGN)
Medtronic
Illumina (ILMN)
Abbott Laboratories (ABT)
Mylan
Becton, Dickinson and (BDX)
Cardinal Health (CAH)
UnitedHealth (UNH)
Stryker Corporation (SYK)
Teva Pharmaceutical Industries (TEVA)
Express Scripts Holding

View all positions for Bellevue Asset Management

Top funds holding Cardiovascular Systems

Huntington National Bank

View all funds holding Cardiovascular Systems